TNHA COMMENTS ON SAHPRA ROADMAP AND TRANSITIONAL PROCESS FOR THE REGULATION OF CATEGORY D MEDICINES (16 July 2023)
Official TNHA comments submitted to SAHPRA in relation to the Roadmap and Transitional Process for the Regulation of Category D Medicines (16 July 2023). The TNHA rejects the unlawful manner in which SAHPRA is attempting to revive and validate the constitutionally flawed complementary medicine regulations in a continued unlawful manner, and which were stuck down by the full bench of the Supreme Court of Appeal in April 2022. This contemptuous and recalcitrant behavior will not... Read More